PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis. - Tefferi A; Fathima S; Alsugair AKA; Aperna F; Natu A; Abdelmagid MG; Csizmar CM; Gurney M; Lasho TL; Finke CM; Mangaonkar AA; Al-Kali A; et al. (American journal of hematology, 2024)